Silence Therapeutics Plc (SLN)
13.30
-0.25
(-1.85%)
USD |
NASDAQ |
Sep 10, 16:00
13.30
0.00 (0.00%)
After-Hours: 20:00
Silence Therapeutics EPS Diluted (Quarterly) : -0.2602 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2602 |
| March 31, 2026 | -0.3161 |
| December 31, 2025 | -0.2488 |
| September 30, 2025 | -0.4409 |
| June 30, 2025 | -0.5863 |
| March 31, 2025 | -0.6064 |
| September 30, 2024 | -0.7461 |
| June 30, 2024 | -0.4201 |
| March 31, 2024 | -0.0526 |
| Date | Value |
|---|---|
| December 31, 2023 | -0.4513 |
| September 30, 2023 | -0.2799 |
| June 30, 2023 | -0.36 |
| March 31, 2023 | -0.3446 |
| December 31, 2022 | -0.4492 |
| September 30, 2022 | -0.2537 |
| June 30, 2022 | -0.5003 |
| March 31, 2022 | -0.3443 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | -0.0437 |
| NuCana Plc | -1.007 |
| Autolus Therapeutics Plc | -0.1472 |
| Compass Pathways Plc | -1.883 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.29M |
| Total Expenses (Quarterly) | 12.29M |
| Enterprise Value | 568.25M |
| Earnings Yield | -9.52% |
| Normalized Earnings Yield | -9.520 |